What Is the Best Injection for Weight Loss? A Complete Guide

There is no single best injection for weight loss that suits every person, but the clinical evidence points to a clear ranking. Tirzepatide (sold as Zepbound) has produced the largest average weight loss in trials, followed by semaglutide (Wegovy), then liraglutide (Saxenda). The right choice still depends on your health history, side-effect tolerance, insurance coverage, and personal goals, so it is a decision to make with a licensed healthcare professional.

FDA-Approved Weight Loss Injections Compared

Three injectable medications are FDA-approved specifically for chronic weight management in the United States. All are prescription products designed to be used alongside a reduced-calorie diet and regular physical activity.

Injection	Active Ingredient	Drug Class	Average Weight Loss in Trials	Dosing
Zepbound	Tirzepatide	GIP and GLP-1 dual agonist	About 21% at 72 weeks (15 mg)	Once weekly
Wegovy	Semaglutide	GLP-1 agonist	About 15% at 68 weeks (2.4 mg)	Once weekly
Saxenda	Liraglutide	GLP-1 agonist	About 8% at 56 weeks (3.0 mg)	Once daily

Those figures are averages from large studies, not promises. Individual results vary widely, and some people lose far more or far less than the trial average.

Tirzepatide has produced the largest average weight loss of any FDA-approved weight loss injection to date.

How Weight Loss Injections Actually Work

Semaglutide and liraglutide mimic GLP-1, a hormone your gut releases after you eat. Tirzepatide mimics GLP-1 and a second hormone called GIP.

Both hormone pathways signal fullness to the brain, slow stomach emptying, and improve blood sugar control. In practice, that usually means eating smaller portions without constant hunger rather than forcing yourself through a strict diet.

These medications change appetite signaling instead of burning fat directly, which is why they generally work only while they are being taken. In clinical trials, most participants regained much of the lost weight after stopping treatment.

Tirzepatide vs. Semaglutide: Which Is Better for Weight Loss?

The query tirzepatide vs semaglutide which is better for weight loss comes up constantly, yet no large head-to-head trial has compared the two drugs at their highest doses. Clinicians rely on results from separate studies instead.

• In SURMOUNT-1, adults without diabetes who took tirzepatide 15 mg lost about 21% of their body weight on average over 72 weeks.
• In STEP-1, adults without diabetes who took semaglutide 2.4 mg lost about 15% of their body weight on average over 68 weeks.

Tirzepatide beat semaglutide on average weight loss in those separate trials, but cross-trial comparisons are imperfect because the study populations, dosing schedules, and timelines were not identical.

Semaglutide has a longer real-world safety record, having been sold as Ozempic since 2017 and as Wegovy since 2021. Tirzepatide reached the market later, as Mounjaro in 2022 and Zepbound in 2023.

Compounded Versions, Bac Water, and Quality Concerns

Drug shortages pushed many people toward compounded semaglutide and tirzepatide sold by telehealth companies and online vendors. Compounded versions are not FDA-approved, and their potency, purity, and dosing can differ from brand-name products.

Anyone researching what is bacteriostatic water for injection used for should know it is sterile water with 0.9% benzyl alcohol, which discourages bacterial growth and is used to dissolve freeze-dried peptide powder. The question what is the best bac water for peptides usually comes down to using a reputable supplier and the correct concentration, because contaminated or mislabeled water carries a real infection risk.

A related question, which semaglutide is best for weight loss, has no universal answer for compounded products because formulation quality varies between pharmacies. Brand-name Wegovy remains the only semaglutide specifically FDA-approved for weight loss.

Safety and Side Effects You Should Know

A frequent search — is tirz safe for weight loss — reflects legitimate concern about pancreatitis, gallbladder disease, and a boxed warning for thyroid C-cell tumors. These medications are not appropriate for people with a personal or family history of medullary thyroid cancer or MEN2 syndrome.

Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. Most are mild to moderate and ease as the dose is increased gradually over several weeks.

Rapid weight loss can also reduce lean muscle mass, so eating enough protein and doing resistance training matters during treatment. People with a history of pancreatitis, kidney disease, or an eating disorder should review the risks with a doctor before starting.

Weight loss injections are not recommended during pregnancy, and anyone planning to conceive should stop treatment well before becoming pregnant.

How to Choose the Right Injection for You

1. Check eligibility. These drugs are intended for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol.
2. Review your history. Prior pancreatitis, gallbladder problems, kidney issues, and a family history of thyroid cancer all affect which option is safer.
3. Compare insurance coverage. Coverage varies enormously between plans, and cost often decides the choice as much as clinical data does.
4. Weigh convenience. Weekly injections are easier for most people to stick with than daily ones.
5. Set realistic expectations. A 10% to 20% reduction in body weight is a strong result, and it can meaningfully improve blood pressure, blood sugar, and sleep apnea.

The Bottom Line

Tirzepatide is the best injection for weight loss on average based on FDA-approved trial data, and semaglutide is a close second with a longer safety history. Neither is right for everyone, and both require a prescription, medical supervision, and a long-term commitment. The most reliable next step is a conversation with a clinician who knows your health history.

COMMON QUESTIONS

Frequently Asked Questions

What is the best injection for weight loss?

Based on average results in FDA-reviewed trials, tirzepatide (Zepbound) is the most effective FDA-approved weight loss injection, with roughly 21% average body weight loss at 72 weeks. Semaglutide (Wegovy) follows at about 15%, and liraglutide (Saxenda) at about 8%. The best option for a specific person depends on medical history, side effects, and insurance coverage.

Are weight loss injections safe?

Semaglutide and tirzepatide are FDA-approved and generally well tolerated, but both carry a boxed warning about thyroid C-cell tumors and can cause pancreatitis and gallbladder disease. Nausea, vomiting, and constipation are the most common side effects. People with a history of medullary thyroid cancer or MEN2 syndrome should not use them, and they are not recommended during pregnancy.

How long do you have to stay on weight loss injections?

Clinical trials show that most people regain much of the lost weight within a year of stopping, so these drugs are usually treated as long-term therapy. Some people can taper to a lower maintenance dose, but that decision should be made with a doctor. Lifestyle habits such as high protein intake and strength training help preserve results.